Dabrafenib Impurity 28 | CAS 1195768-20-7 - Request Quote
Dabrafenib Impurity 28
| SZ CAT No: | SZ-D120042 |
| CAS No | 1195768-20-7 |
| Mol.F. | C18H11ClF3N3O3S |
| Mol.Wt. | 441.8 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabrafenib Impurity 28 is chemically N-(3-(2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide. Dabrafenib Impurity 28 is supplied with detailed characterization data compliant with regulatory guideline. Dabrafenib Impurity 28 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabrafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1195768-20-7
Purchase 1195768-20-7
Order 1195768-20-7
Enquire 1195768-20-7
price of 1195768-20-7
1195768-20-7 Supplier
1195768-20-7 Manufacturer
1195768-20-7 Exporter
buy high quality Dabrafenib Impurity 28
Purchase Dabrafenib Impurity 28
Dabrafenib Impurity 28 suppliers
Dabrafenib Impurity 28 manufacturers
Dabrafenib Impurity 28 price
Order Dabrafenib Impurity 28
Enquire Dabrafenib Impurity 28
Dabrafenib Impurity 28 cost
Dabrafenib Impurity 28 Supplier
Dabrafenib Impurity 28 Distributor
Dabrafenib Impurity 28 for Method Validation
Dabrafenib Reference Standard
Dabrafenib Impurity 28 for ANDA Filing
Dabrafenib Impurity 28 for Forced Degradation Studies
Dabrafenib Impurity 28 Identification Standards
Dabrafenib Impurity 28 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.